Histogen Inc (HSTO)
0.12
-0.23
(-65.82%)
USD |
OTCM |
May 01, 14:15
Histogen Max Drawdown (5Y): 99.96% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.96% |
| March 31, 2024 | 99.96% |
| February 29, 2024 | 99.96% |
| January 31, 2024 | 99.96% |
| December 31, 2023 | 99.96% |
| November 30, 2023 | 99.96% |
| October 31, 2023 | 99.96% |
| September 30, 2023 | 99.96% |
| August 31, 2023 | 99.95% |
| July 31, 2023 | 99.95% |
| June 30, 2023 | 99.95% |
| May 31, 2023 | 99.95% |
| April 30, 2023 | 99.95% |
| March 31, 2023 | 99.95% |
| February 28, 2023 | 99.95% |
| January 31, 2023 | 99.95% |
| December 31, 2022 | 99.95% |
| November 30, 2022 | 99.94% |
| October 31, 2022 | 99.92% |
| September 30, 2022 | 99.91% |
| August 31, 2022 | 99.88% |
| July 31, 2022 | 99.86% |
| June 30, 2022 | 99.86% |
| May 31, 2022 | 99.79% |
| April 30, 2022 | 99.75% |
| Date | Value |
|---|---|
| March 31, 2022 | 99.75% |
| February 28, 2022 | 99.75% |
| January 31, 2022 | 99.75% |
| December 31, 2021 | 99.63% |
| November 30, 2021 | 99.45% |
| October 31, 2021 | 99.20% |
| September 30, 2021 | 99.15% |
| August 31, 2021 | 99.15% |
| July 31, 2021 | 99.14% |
| June 30, 2021 | 99.14% |
| May 31, 2021 | 99.14% |
| April 30, 2021 | 99.14% |
| March 31, 2021 | 99.14% |
| February 28, 2021 | 99.14% |
| January 31, 2021 | 99.14% |
| December 31, 2020 | 99.14% |
| November 30, 2020 | 98.35% |
| October 31, 2020 | 98.35% |
| September 30, 2020 | 98.35% |
| August 31, 2020 | 97.79% |
| July 31, 2020 | 97.55% |
| June 30, 2020 | 97.55% |
| May 31, 2020 | 97.55% |
| April 30, 2020 | 97.55% |
| March 31, 2020 | 97.55% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
93.32%
Minimum
May 2019
99.96%
Maximum
Sep 2023
98.98%
Average
99.33%
Median
Max Drawdown (5Y) Benchmarks
| CEL-SCI Corp | 96.13% |
| AIM ImmunoTech Inc | 99.76% |
| IGC Pharma Inc | 97.77% |
| NovaBay Pharmaceuticals Inc | 99.91% |
| Protalix BioTherapeutics Inc | 94.35% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -83.25 |
| Beta (5Y) | 0.913 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 82.20% |
| Historical Sharpe Ratio (5Y) | -0.889 |
| Historical Sortino (5Y) | -1.513 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.80% |